Respinor
Oslo
About Respinor
Respinor develops an ultrasound sensor for continuous monitoring of the diaphragm, the main breathing muscle. The company's technology has a broad range of potential benefits and represents a technology platform for applications in critical care and in respiratory medicine. Respinor aims to seize a major market opportunity through the clinical validation, technology maturation and commercialization of a unique ultrasound technology for Diaphragm Monitoring – DiaMon. DiaMon is a non-invasive ultrasound device that is designed to provide precise, continuous and real-time information of diaphragm function.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Last round: Series Unknown (Jan 2017)
- Website: respinor.com
- Phone: +47 21 62 79 80
Industries & Categories
Health Diagnostics, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/respinor-41957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.